2 years ago
CABA
AnalystsSamantha SemenkowSamantha Semenkow's Stock Forecasts
AnalystsSamantha Semenkow
Sectors:
Analyst Ranking
Bottom 6%
#4813 out of 5069 analysts
Average Return
-9.02%
Win Rate
40%17 out of 43
Risk vs Reward
Poor
Good
Samantha Semenkow's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Morphic Holding IncMORF | +109.75% | $27.17 | $56.99 | 2023-12-08 - 2024-08-16 | Strong Buy |
Larimar Therapeutics IncLRMR | +103.34% | $3.29 | $6.69 | 2023-11-17 - 2024-11-15 | Strong Buy |
Immunovant IncIMVT | +78.11% | $16.17 | $28.80 | 2023-04-25 - 2024-04-24 | Strong Buy |
Cabaletta Bio IncCABA | +72.73% | $1.65 | $2.85 | 2025-08-14 - 2025-10-17 | Strong Buy |
Argenx SeARGX | +53.96% | $543.84 | $837.28 | 2024-10-17 - 2025-10-16 | Strong Buy |
Samantha Semenkow Analyst Color
Get additional color on Samantha Semenkow's coverage of popular stocks
2 years ago
EDIT
2 years ago
LRMR
Samantha Semenkow's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Moonlake ImmunotherapeuticsMLTX | 2 | Hold | $5.00 | -45.18% | Downgrades | 19 days ago |
Biohaven LtdBHVN | 1 | Strong Buy | $28.00 | +75.55% | Initiates Coverage On | a month ago |
Roivant Sciences LtdROIV | 1 | Strong Buy | $16.00 | -7.30% | Initiates Coverage On | 2 months ago |
Cabaletta Bio IncCABA | 4 | Strong Buy | $10.00 | +250.88% | Maintains | 2 months ago |
Wave Life Sciences LtdWVE | 1 | Strong Buy | $16.00 | +104.87% | Initiates Coverage On | 3 months ago |
Prime Medicine IncPRME | 3 | Hold | $1.50 | -72.48% | Downgrades | 5 months ago |
Allogene Therapeutics IncALLO | 3 | Strong Buy | $4.00 | +225.20% | Maintains | 5 months ago |
Argenx SeARGX | 6 | Strong Buy | $803.00 | -4.82% | Maintains | 5 months ago |
Structure Therapeutics IncGPCR | 1 | Strong Buy | $60.00 | +119.14% | Initiates Coverage On | 6 months ago |
Bioage Labs IncBIOA | 3 | Hold | $5.00 | -3.47% | Maintains | 7 months ago |
Acelyrin IncSLRN | 2 | Hold | $3.00 | +32.16% | Maintains | 9 months ago |
Voyager Therapeutics IncVYGR | 1 | Strong Buy | $12.00 | +142.42% | Initiates Coverage On | a year ago |
Catalyst Pharmaceuticals IncCPRX | 2 | Strong Buy | $31.00 | N/A | Maintains | a year ago |
Sana Biotechnology IncSANA | 2 | Strong Buy | $15.00 | N/A | Maintains | a year ago |
Sensei Biotherapeutics IncSNSE | 2 | Strong Buy | $80.00 | N/A | Reinstates | a year ago |
Larimar Therapeutics IncLRMR | 6 | Strong Buy | $14.00 | N/A | Maintains | a year ago |
Editas Medicine IncEDIT | 4 | Strong Buy | $15.00 | N/A | Maintains | a year ago |
2seventy Bio IncTSVT | 2 | Strong Buy | $12.00 | N/A | Maintains | 2 years ago |
Morphic Holding IncMORF | 1 | Strong Buy | $46.00 | N/A | Initiates Coverage On | 2 years ago |
Immunovant IncIMVT | 3 | Strong Buy | $50.00 | N/A | Maintains | 2 years ago |
Beam Therapeutics IncBEAM | 3 | Strong Buy | $56.00 | N/A | Maintains | 2 years ago |
9 Meters Biopharma IncNMTRQ | 3 | Hold | $0.75 | N/A | Maintains | 2 years ago |
Ngm Biopharmaceuticals IncNGM | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.